Seems decent.
Capped off my trading year, otherwise I would hold it for $2s
If this was released last week, the stock would have had a better run.
However, someone may start building now and the stock may pop in the new year.
Capped off my trading year, otherwise I would hold it for $2s
If this was released last week, the stock would have had a better run.
However, someone may start building now and the stock may pop in the new year.
Recent BMRA News
- Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs • GlobeNewswire Inc. • 04/14/2026 12:19:00 PM
- Biomerica Reports Third Quarter Fiscal 2026 Financial Results • GlobeNewswire Inc. • 04/13/2026 10:57:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/13/2026 09:15:20 PM
- Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laboratory Chains in Europe • GlobeNewswire Inc. • 03/18/2026 12:19:00 PM
- Biomerica Receives MHRA Registration for hp+detect™, Allowing Commercial Sales in Great Britain • GlobeNewswire Inc. • 03/05/2026 01:19:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/27/2026 10:15:26 PM
- Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy • GlobeNewswire Inc. • 02/26/2026 01:19:00 PM
- Vietnam Approves Biomerica’s EZ Detect™ for Nationwide Distribution • GlobeNewswire Inc. • 02/18/2026 01:19:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/28/2026 10:40:25 PM
- Biomerica Reports Second Quarter Fiscal 2026 Financial Results • GlobeNewswire Inc. • 01/14/2026 10:17:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/14/2026 10:15:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/31/2025 10:10:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/31/2025 10:10:03 PM
- Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test • GlobeNewswire Inc. • 12/23/2025 01:19:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/16/2025 01:19:33 PM
- Egyptian Drug Authority Authorizes Biomerica’s Complete Screening Test Portfolio • GlobeNewswire Inc. • 12/11/2025 01:08:00 PM
- Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS • GlobeNewswire Inc. • 11/25/2025 01:19:00 PM
- Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand • GlobeNewswire Inc. • 11/06/2025 01:19:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/23/2025 08:15:04 PM
- Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S. • GlobeNewswire Inc. • 10/16/2025 12:19:00 PM
- Biomerica Reports First Quarter Fiscal 2026 Financial Results • GlobeNewswire Inc. • 10/15/2025 01:27:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/14/2025 09:11:06 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/09/2025 09:15:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/08/2025 12:19:33 PM
- Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors • GlobeNewswire Inc. • 10/08/2025 12:19:00 PM
